Cargando…

In vivo persistence of adoptively transferred TCR gene-transduced lymphocytes with anti-tumor reactivity in patients with MAGE-A4 expressing esophageal cancer

Detalles Bibliográficos
Autores principales: Ikeda, Hiroaki, Kageyama, Shinichi, Imai, Naoko, Miyahara, Yoshihiro, Ishihara, Mikiya, Katayama, Naoyuki, Yoshioka, Hirofumi, Tomura, Daisuke, Nukaya, Ikuei, Mineno, Junichi, Takesako, Kazuto, Shiku, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991198/
http://dx.doi.org/10.1186/2051-1426-1-S1-O3
_version_ 1782312393174417408
author Ikeda, Hiroaki
Kageyama, Shinichi
Imai, Naoko
Miyahara, Yoshihiro
Ishihara, Mikiya
Katayama, Naoyuki
Yoshioka, Hirofumi
Tomura, Daisuke
Nukaya, Ikuei
Mineno, Junichi
Takesako, Kazuto
Shiku, Hiroshi
author_facet Ikeda, Hiroaki
Kageyama, Shinichi
Imai, Naoko
Miyahara, Yoshihiro
Ishihara, Mikiya
Katayama, Naoyuki
Yoshioka, Hirofumi
Tomura, Daisuke
Nukaya, Ikuei
Mineno, Junichi
Takesako, Kazuto
Shiku, Hiroshi
author_sort Ikeda, Hiroaki
collection PubMed
description
format Online
Article
Text
id pubmed-3991198
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39911982014-05-05 In vivo persistence of adoptively transferred TCR gene-transduced lymphocytes with anti-tumor reactivity in patients with MAGE-A4 expressing esophageal cancer Ikeda, Hiroaki Kageyama, Shinichi Imai, Naoko Miyahara, Yoshihiro Ishihara, Mikiya Katayama, Naoyuki Yoshioka, Hirofumi Tomura, Daisuke Nukaya, Ikuei Mineno, Junichi Takesako, Kazuto Shiku, Hiroshi J Immunother Cancer Oral Presentation BioMed Central 2013-11-07 /pmc/articles/PMC3991198/ http://dx.doi.org/10.1186/2051-1426-1-S1-O3 Text en Copyright © 2013 Ikeda et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Oral Presentation
Ikeda, Hiroaki
Kageyama, Shinichi
Imai, Naoko
Miyahara, Yoshihiro
Ishihara, Mikiya
Katayama, Naoyuki
Yoshioka, Hirofumi
Tomura, Daisuke
Nukaya, Ikuei
Mineno, Junichi
Takesako, Kazuto
Shiku, Hiroshi
In vivo persistence of adoptively transferred TCR gene-transduced lymphocytes with anti-tumor reactivity in patients with MAGE-A4 expressing esophageal cancer
title In vivo persistence of adoptively transferred TCR gene-transduced lymphocytes with anti-tumor reactivity in patients with MAGE-A4 expressing esophageal cancer
title_full In vivo persistence of adoptively transferred TCR gene-transduced lymphocytes with anti-tumor reactivity in patients with MAGE-A4 expressing esophageal cancer
title_fullStr In vivo persistence of adoptively transferred TCR gene-transduced lymphocytes with anti-tumor reactivity in patients with MAGE-A4 expressing esophageal cancer
title_full_unstemmed In vivo persistence of adoptively transferred TCR gene-transduced lymphocytes with anti-tumor reactivity in patients with MAGE-A4 expressing esophageal cancer
title_short In vivo persistence of adoptively transferred TCR gene-transduced lymphocytes with anti-tumor reactivity in patients with MAGE-A4 expressing esophageal cancer
title_sort in vivo persistence of adoptively transferred tcr gene-transduced lymphocytes with anti-tumor reactivity in patients with mage-a4 expressing esophageal cancer
topic Oral Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991198/
http://dx.doi.org/10.1186/2051-1426-1-S1-O3
work_keys_str_mv AT ikedahiroaki invivopersistenceofadoptivelytransferredtcrgenetransducedlymphocyteswithantitumorreactivityinpatientswithmagea4expressingesophagealcancer
AT kageyamashinichi invivopersistenceofadoptivelytransferredtcrgenetransducedlymphocyteswithantitumorreactivityinpatientswithmagea4expressingesophagealcancer
AT imainaoko invivopersistenceofadoptivelytransferredtcrgenetransducedlymphocyteswithantitumorreactivityinpatientswithmagea4expressingesophagealcancer
AT miyaharayoshihiro invivopersistenceofadoptivelytransferredtcrgenetransducedlymphocyteswithantitumorreactivityinpatientswithmagea4expressingesophagealcancer
AT ishiharamikiya invivopersistenceofadoptivelytransferredtcrgenetransducedlymphocyteswithantitumorreactivityinpatientswithmagea4expressingesophagealcancer
AT katayamanaoyuki invivopersistenceofadoptivelytransferredtcrgenetransducedlymphocyteswithantitumorreactivityinpatientswithmagea4expressingesophagealcancer
AT yoshiokahirofumi invivopersistenceofadoptivelytransferredtcrgenetransducedlymphocyteswithantitumorreactivityinpatientswithmagea4expressingesophagealcancer
AT tomuradaisuke invivopersistenceofadoptivelytransferredtcrgenetransducedlymphocyteswithantitumorreactivityinpatientswithmagea4expressingesophagealcancer
AT nukayaikuei invivopersistenceofadoptivelytransferredtcrgenetransducedlymphocyteswithantitumorreactivityinpatientswithmagea4expressingesophagealcancer
AT minenojunichi invivopersistenceofadoptivelytransferredtcrgenetransducedlymphocyteswithantitumorreactivityinpatientswithmagea4expressingesophagealcancer
AT takesakokazuto invivopersistenceofadoptivelytransferredtcrgenetransducedlymphocyteswithantitumorreactivityinpatientswithmagea4expressingesophagealcancer
AT shikuhiroshi invivopersistenceofadoptivelytransferredtcrgenetransducedlymphocyteswithantitumorreactivityinpatientswithmagea4expressingesophagealcancer